// App-Quantinova.ai

475 : Influence of cirrhosis on outcomes of patients with advanced intrahepatic cholangiocarcinoma receiving chemotherapy.

Researchers

Presenter

  • Constance D'abrigeon

Principal Investigators

  • Mairead Geraldine McNamara

  • Samuel Le Sourd

  • Angela Lamarca

  • Astrid Livre

  • Richard A Hubner

  • Juan W. Valle

  • Julien Edeline

Medical Centers

  • Centre Eugene-Marquis, Rennes, France

  • Princess Margaret Cancer Center, Toronto, ON, Canada

  • Centre Eugene-Marquis, Rennes, France

  • The Christie NHS Foundation TRUST, Manchester, United Kingdom

  • Department of Gastroenterology, CHU Pontchaillou, INSERM U1242, "Chemistry, Oncogenesis Stress Signaling", Rennes 1 University, Rennes, France

  • Medical Oncology Department, The Christie NHS Foundation Trust, Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom

  • University of Manchester, The Christie Hospital NHS Foundation Trust, Manchester, United Kingdom

  • Centre Eugene-Marquis, Rennes, France

Locations

  • France

  • Canada

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

  • Cardiovascular (CVS)

  • Oncology (ONC)

Disease

  • Advanced biliary tract carcinoma

  • Portal Hypertension

  • Hypertension

  • Cirrhosis

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Gemcitabine

  • Oxaliplatin

  • Cisplatin

Outcome

  • N/A


Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A